What RxCrossroads does

RxCrossroads is a B2B hub services provider that connects patients with specialty pharmaceutical therapies, operating from Louisville, Kentucky with 10,000+ employees. The company delivers structured programs organized around four pillars — access, affordability, adherence, and analytics — covering benefits verification, prior authorization processing, copay assistance enrollment, adherence support, and temperature-controlled specialty drug distribution. Its primary customer segment is specialty pharmaceutical manufacturers developing high-cost therapies, including cell and gene therapy programs where RxCrossroads has over a decade of specialized experience.

The underlying technology stack combines benefits verification platforms, prior authorization processing systems, copay assistance enrollment tools, and temperature-controlled drug delivery infrastructure with cold-chain capabilities. RxCrossroads has accumulated 1.5M+ sq.ft. across its core distribution centers and operates within McKesson's Third Party Logistics network, which ships over 2 billion units annually at 99.98% accuracy. The model blends technology platforms with high-touch human patient support.

Commercially, RxCrossroads generates revenue as managed services fees from pharmaceutical manufacturer clients for hub program deployment and ongoing patient support. The company is privately held and has been a McKesson subsidiary since 2017, when McKesson acquired it from CVS Health. It sits within McKesson's Biopharma Capabilities segment alongside offerings in pharmaceutical distribution, oncology and multispecialty solutions, and prescription benefit solutions.

Name

RxCrossroads

Legal name

RxCrossroads

Website

https://rxcrossroads.com

Company type

Private

Founded year

1986

Operating status

Acquired

Headcount range

5,001–10,000 employees

Short description

RxCrossroads is a B2B hub services provider for specialty pharmaceutical manufacturers, delivering benefits verification, prior authorization, copay assistance, adherence support, and temperature-controlled drug distribution. Operating as a McKesson subsidiary since 2017, the Louisville-based company employs 10,000+ staff.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Hub Services

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Patient Access Programs & Affordability (Copay/Hubs/PSP) (HLAIAKAG)

akta.pro secondary industries

Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ), Pharmaceuticals & Life Sciences Forwarding (GxP/GDP) (TLACAJAB)

Keywords

• Specialty pharmaceutical hub services
• Patient access support
• Benefits verification services
• Prior authorization processing
• Specialty drug distribution

Headquarters

HQ city

Louisville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Hub Services Revenue: RxCrossroads generates revenue by providing hub services to specialty pharmaceutical manufacturers, including benefits verification, prior authorization support, copay assistance enrollment, and specialty drug distribution services.

Go-to-market motion1 record

Distribution channels1 record

Core offering

RxCrossroads provides B2B hub services for specialty pharmaceutical manufacturers, structured around four pillars: access, affordability, adherence, and analytics. Its offerings include benefits verification, prior authorization processing, copay assistance enrollment, temperature-controlled specialty drug distribution (3PL), and patient adherence programs designed to help patients start and stay on complex, high-cost specialty medications.

Product overview

RxCrossroads is a hub services provider that was acquired by McKesson from CVS Health. Based on industry context, RxCrossroads provides hub services and patient support solutions for the specialty pharmaceutical industry. However, the source data does not contain specific product details, service names, or descriptions of RxCrossroads's individual offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Benefits Verification Technology-enabled benefits verification service that streamlines insurance coverage confirmation for patients requiring specialty medications, offered to specialty pharmaceutical manufacturers.
• Prior Authorization Processing Service that handles prior authorization requirements between providers, payers, and manufacturers to reduce delays in patient access to specialty medications.
• Copay Assistance Enrollment Technology-enabled enrollment service for copay assistance programs that helps patients afford high-cost specialty medications, offered to specialty pharmaceutical manufacturers.
• Temperature-Controlled Specialty Drug Distribution Specialized third-party logistics (3PL) service providing cold-chain capable, temperature-controlled distribution of specialty medications including cell and gene therapies, with more than 2 billion units shipped annually and 99.98% inventory and order accuracy rates through McKesson integration.
• Patient Adherence Programs High-touch support programs that help patients starting on specialty therapies to remain adherent to treatment, combining human outreach with analytics-driven patient journey insights.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• McKessoncoreOthers · 1 January 2017McKesson acquired RxCrossroads from CVS Health in 2017, integrating the hub services provider into McKesson's Biopharma Capabilities segment. This acquisition provides RxCrossroads with access to McKesson's extensive pharmaceutical distribution network and supply chain infrastructure.

Recent moves4 records

Expansion highlights4 records

Direct peers

• ConnectiveRx: ConnectiveRx delivers manufacturer hub services including copay, benefit verification, and patient support programs for specialty brands — directly comparable to RxCrossroads' specialty manufacturer services.
• CareMetx: CareMetx provides specialty hub, prior authorization, copay assistance, and adherence services to biopharma manufacturers — a near-direct competitor operating the same four-pillar (access, affordability, adherence, engagement) hub model.
• Sonexus Health: Sonexus Health (formerly part of Express Scripts/Medco) provides patient access and hub services for specialty pharma manufacturers, covering copay support, prior authorization, and adherence — a direct hub-services peer.
• Asembia: Asembia is a leading specialty pharmacy hub services provider working with biopharma manufacturers on patient access, copay, and adherence programs — directly comparable to RxCrossroads' hub offering across manufacturers and therapies.
• Eversana (Lash Group): Eversana's Lash Group provides patient services and hub solutions for biopharma manufacturers; comparable to RxCrossroads across patient access, adherence, and specialty distribution support.

Broad incumbents

• CVS Specialty (CVS Health): CVS Specialty is the specialty pharmacy and patient services arm of CVS Health — RxCrossroads' former parent — and a broad incumbent offering hub-adjacent services across payer, manufacturer, and dispensing relationships.
• Optum Rx Specialty: Optum Rx Specialty is UnitedHealth Group's specialty pharmacy and hub platform — a vertically integrated incumbent competing directly with RxCrossroads for manufacturer hub business.
• Accredo (Express Scripts): Accredo is Express Scripts' specialty pharmacy and patient services arm covering distribution, hub, and adherence for high-cost therapies — a broader incumbent that competes for both manufacturer services and downstream specialty fulfillment.
• Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy combines specialty distribution with manufacturer hub-adjacent services for oncology, autoimmune, and other high-cost therapies — comparable to RxCrossroads on the fulfillment-plus-support combined offering.
• McKesson Biopharma Capabilities: McKesson's Biopharma Capabilities segment — RxCrossroads' own parent business — competes at a broader scale than RxCrossroads alone and is the closest internal-comparable divisional reference for the services RxCrossroads provides.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RxCrossroads